American Journal of Psychiatry · 1988 · 51 citations · 15 references
MedicinePharmacologyPharmacotherapyNeuropharmacologyPsychiatric PharmacotherapyPsychopharmacologyAnxiety Disorder PharmacotherapyAnxiety DisordersAnxiety ManagementAnxiolytic PharmacologyAnxiolytic PharmacotherapyDouble-blind TrialsPharmacological Anxiety ManagementRebound Anxiety
Sixty-two anxious patients were treated under double-blind conditions for 4 weeks with either clorazepate or lorazepam. Two-thirds of each treatment group were then switched abruptly to placebo for 2 weeks, while one-third continued to receive active medication. Two major findings were obtained. About 70% of the patients maintained improvement during the 2-week placebo period. Some patients, however, experienced rebound anxiety, which appeared to be more intense and occurred earlier when placebo was substituted for a benzodiazepine with a short half-life (lorazepam) than for one with a long half-life (clorazepate). The clinical relevance of these findings is discussed.
15
THE ASSESSMENT OF ANXIETY STATES BY RATING
Max Hamilton · British Journal of Medical Psychology · 1959 · 11.4K citations
An analysis of mood in neurotics.
Douglas M. McNair, Maurice Lorr · Journal of Abnormal & Social Psychology · 1964 · 563 citations
Differential Response to Chlorpromazine, Imipramine, and Placebo
Allen Raskin · Archives of General Psychiatry · 1970 · 301 citations
Medicine, Pharmacology, Psychiatry +12
Long-term Diazepam Therapy and Clinical Outcome
Karl Rickels · JAMA · 1983 · 267 citations
Rebound Insomnia: A New Clinical Syndrome
Anthony Kales, Martin B. Scharf, Joyce D. Kales · Science · 1978 · 200 citations